| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.9B | $0.9B | $0.9B | $0.7B | $0.7B | $0.7B | $0.8B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $0.46 | $4.73 | $4.48 | $1.76 | $4.22 | $2.21 | $1.00 | $0.78 |
| EPS (Diluted) | $0.46 | $4.71 | $4.45 | $1.75 | $4.17 | $2.19 | $0.99 | $0.77 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.4B | $3.5B | $3.6B | $3.7B | $3.8B | $3.9B | $4.0B | $3.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $2.5B | $2.5B | $2.5B | $2.8B | $2.6B | $2.7B | $2.8B | $2.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.0B | $1.1B | $1.0B | $0.9B | $1.2B | $1.2B | $1.2B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.1B | $0.0B | $0.1B | $0.0B | $0.0B | $0.1B | $0.2B |
| Investing Cash Flow | $0.2B | $-0.2B | $0.4B | $-0.1B | $-0.0B | $0.1B | $0.0B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.1B | $-0.3B | $0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.0B |